rs34500739

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006031.6(PCNT):​c.711T>G​(p.His237Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0542 in 1,612,714 control chromosomes in the GnomAD database, including 2,673 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H237R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.050 ( 231 hom., cov: 32)
Exomes 𝑓: 0.055 ( 2442 hom. )

Consequence

PCNT
NM_006031.6 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.738

Publications

19 publications found
Variant links:
Genes affected
PCNT (HGNC:16068): (pericentrin) The protein encoded by this gene binds to calmodulin and is expressed in the centrosome. It is an integral component of the pericentriolar material (PCM). The protein contains a series of coiled-coil domains and a highly conserved PCM targeting motif called the PACT domain near its C-terminus. The protein interacts with the microtubule nucleation component gamma-tubulin and is likely important to normal functioning of the centrosomes, cytoskeleton, and cell-cycle progression. Mutations in this gene cause Seckel syndrome-4 and microcephalic osteodysplastic primordial dwarfism type II. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
PCNT Gene-Disease associations (from GenCC):
  • microcephalic osteodysplastic primordial dwarfism type II
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Moyamoya disease
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0030015707).
BP6
Variant 21-46346199-T-G is Benign according to our data. Variant chr21-46346199-T-G is described in ClinVar as Benign. ClinVar VariationId is 138615.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0611 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCNTNM_006031.6 linkc.711T>G p.His237Gln missense_variant Exon 4 of 47 ENST00000359568.10 NP_006022.3 O95613-1
PCNTNM_001315529.2 linkc.357T>G p.His119Gln missense_variant Exon 4 of 47 NP_001302458.1 O95613-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCNTENST00000359568.10 linkc.711T>G p.His237Gln missense_variant Exon 4 of 47 1 NM_006031.6 ENSP00000352572.5 O95613-1

Frequencies

GnomAD3 genomes
AF:
0.0503
AC:
7631
AN:
151752
Hom.:
232
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0379
Gnomad AMI
AF:
0.0274
Gnomad AMR
AF:
0.0339
Gnomad ASJ
AF:
0.0642
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00871
Gnomad FIN
AF:
0.0846
Gnomad MID
AF:
0.0287
Gnomad NFE
AF:
0.0627
Gnomad OTH
AF:
0.0482
GnomAD2 exomes
AF:
0.0459
AC:
11544
AN:
251320
AF XY:
0.0452
show subpopulations
Gnomad AFR exome
AF:
0.0376
Gnomad AMR exome
AF:
0.0217
Gnomad ASJ exome
AF:
0.0648
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0861
Gnomad NFE exome
AF:
0.0611
Gnomad OTH exome
AF:
0.0499
GnomAD4 exome
AF:
0.0546
AC:
79811
AN:
1460848
Hom.:
2442
Cov.:
33
AF XY:
0.0535
AC XY:
38885
AN XY:
726768
show subpopulations
African (AFR)
AF:
0.0356
AC:
1190
AN:
33458
American (AMR)
AF:
0.0235
AC:
1051
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.0637
AC:
1664
AN:
26102
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39632
South Asian (SAS)
AF:
0.0135
AC:
1162
AN:
86246
European-Finnish (FIN)
AF:
0.0832
AC:
4433
AN:
53278
Middle Eastern (MID)
AF:
0.0298
AC:
172
AN:
5768
European-Non Finnish (NFE)
AF:
0.0603
AC:
67061
AN:
1111330
Other (OTH)
AF:
0.0509
AC:
3074
AN:
60340
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
3663
7326
10989
14652
18315
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2430
4860
7290
9720
12150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0503
AC:
7634
AN:
151866
Hom.:
231
Cov.:
32
AF XY:
0.0496
AC XY:
3684
AN XY:
74200
show subpopulations
African (AFR)
AF:
0.0380
AC:
1572
AN:
41400
American (AMR)
AF:
0.0338
AC:
515
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.0642
AC:
222
AN:
3460
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5168
South Asian (SAS)
AF:
0.00893
AC:
43
AN:
4816
European-Finnish (FIN)
AF:
0.0846
AC:
888
AN:
10498
Middle Eastern (MID)
AF:
0.0274
AC:
8
AN:
292
European-Non Finnish (NFE)
AF:
0.0627
AC:
4258
AN:
67946
Other (OTH)
AF:
0.0477
AC:
101
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
359
719
1078
1438
1797
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0543
Hom.:
607
Bravo
AF:
0.0457
TwinsUK
AF:
0.0539
AC:
200
ALSPAC
AF:
0.0581
AC:
224
ESP6500AA
AF:
0.0436
AC:
192
ESP6500EA
AF:
0.0614
AC:
528
ExAC
AF:
0.0465
AC:
5644
Asia WGS
AF:
0.0120
AC:
42
AN:
3478
EpiCase
AF:
0.0548
EpiControl
AF:
0.0541

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 31, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Microcephalic osteodysplastic primordial dwarfism type II Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.77
CADD
Benign
5.7
DANN
Benign
0.38
DEOGEN2
Benign
0.013
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.00020
N
LIST_S2
Benign
0.18
T
MetaRNN
Benign
0.0030
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
-1.6
N
PhyloP100
0.74
PrimateAI
Benign
0.36
T
PROVEAN
Benign
0.78
N
REVEL
Benign
0.037
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.050
MutPred
0.28
Loss of catalytic residue at L236 (P = 0.1265);
MPC
0.081
ClinPred
0.00022
T
GERP RS
3.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.025
gMVP
0.038
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34500739; hg19: chr21-47766113; COSMIC: COSV64033626; COSMIC: COSV64033626; API